Adalimumab 61314-0327-20
Generic: Adalimumab-Adaz
- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761071
Need to source Adalimumab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 40 mg/.4mL |
Drug Class
Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]
Selected Package
61314-0327-20Selected2 SYRINGE in 1 CARTON (61314-327-20) / .4 mL in 1 SYRINGE
Other packages for this product(1)
2 SYRINGE, GLASS in 1 CARTON (61314-327-64) / .4 mL in 1 SYRINGE, GLASS